481
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Features of myocardial injury in severe organophosphate poisoning

, , , , , , & show all
Pages 873-879 | Received 13 Mar 2014, Accepted 09 Jul 2014, Published online: 12 Aug 2014

References

  • Linden CH, Lovejoy FH Jr. Poisoning and drug overdosage. In: Harrison TR, Fauci A, Braunwald E, Isselbacher K, Wilson J, Martin J, et al., eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, Health Professions Division; 1998:2523–2543.
  • Roth A, Zellinger I, Arad M, Atsmon J. Organophosphates and the heart. Chest 1993; 103:576–582.
  • Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999; 54:1073–1088.
  • Ludomirsky A, Klein HO, Sarelli P, Becker B, Hoffman S, Taitelman U, et al. Q-T prolongation and polymorphous (“torsade de pointes”) ventricular arrhythmias associated with organophosphorus insecticide poisoning. Am J Cardiol 1982; 49:1654–1658.
  • Karki P, Ansari JA, Bhandary S, Koirala S. Cardiac and electrocardiographical manifestations of acute organophosphate poisoning. Singapore Med J 2004; 45:385–389.
  • Brill DM, Maisel AS, Prabhu R. Polymorphic ventricular tachycardia and other complex arrhythmias in organophosphate insecticide poisoning. J Electrocardiol 1984; 17:97–102.
  • Wang MH, Tseng CD, Bair SY. Q-T interval prolongation and pleomorphic ventricular tachyarrhythmia (‘Torsade de pointes’) in organophosphate poisoning: report of a case. Hum Exp Toxicol 1998; 17:587–590.
  • World Health Organization. The WHO recommended classification of pesticides by hazard and guidelines to classification: 2004 [Online] 2004; Available at: http://apps.who.int/iris/bitstream/10665/43138/1/9241546638.pdf Accessed on January 01 2014.
  • World Health Organization. Safety of pyrethroids for public health use [Online] 2005; Available at: http://apps.who.int/iris/handle/10665/69008 Accessed on May 17 2008.
  • Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100:609–615.
  • Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 1971; 50:475–492.
  • Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011; 32:404–411.
  • Fishbein MC, Wang T, Matijasevic M, Hong L, Apple FS. Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc Pathol 2003; 12:65–71.
  • Mingels AM, Jacobs LH, Kleijnen VW, Laufer EM, Winkens B, Hofstra L, et al. Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance. Clin Res Cardiol 2010; 99:385–391.
  • Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48:1–11.
  • Anand S, Singh S, Nahar Saikia U, Bhalla A, Paul Sharma Y, Singh D. Cardiac abnormalities in acute organophosphate poisoning. Clin Toxicol (Phila) 2009; 47:230–235.
  • Saadeh AM, Farsakh NA, al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart 1997; 77:461–464.
  • Kose A, Gunay N, Yildirim C, Tarakcioglu M, Sari I, Demiryurek AT. Cardiac damage in acute organophosphate poisoning in rats: effects of atropine and pralidoxime. Am J Emerg Med 2009; 27:169–175.
  • Mahajan VS, Jarolim P. How to interpret elevated cardiac troponin levels. Circulation 2011; 124:2350–2354.
  • American Heart Association Guidelines: management of symptomatic bradycardia and tachycardia. Circulation 2005; 112:IV67.
  • Eddlestone M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, Buckley NA. Early management after self-poisoning with an organophosphorus or carbamate pesticide-a treatment protocol for junior doctors. Crit Care 2004; 8: R391–R397.
  • Sahin I, Onbasi K, Sahin H, Karakaya C, Ustun Y, Noyan T. The prevalence of pancreatitis in organophosphate poisonings. Hum Exp Toxicol 2002; 21:175–177.
  • Lee WC, Yang CC, Deng JF, Wu ML, Ger J, Lin HC, et al. The clinical significance of hyperamylasemia in organophosphate poisoning. J Toxicol Clin Toxicol 1998; 36:673–681.
  • Chhabra M, Sepaha G, Jain S, Bhagwat R, Khandekar J. ECG and necropsy changes in organophosphorus compound (malathion) poisoning. Indian J Med Sci 1970; 24:424–429.
  • Kiss Z, Fazekas T. Arrhythmias in organophosphate poisonings. Acta Cardiol 1979; 34:323–330.
  • Chuang FR, Jang SW, Lin JL, Chern MS, Chen JB, Hsu KT. QTc prolongation indicates a poor prognosis in patients with organophosphate poisoning. Am J Emerg Med 1996; 14:451–453.
  • Bar-Meir E, Schein O, Eisenkraft A, Rubinshtein R, Grubstein A, Militianu A, et al. Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes. Crit Rev Toxicol 2007; 37:279–285.
  • Ozturk MA, Kelestimur F, Kurtoglu S, Guven K, Arslan D. Anticholinesterase poisoning in Turkey–clinical, laboratory and radiologic evaluation of 269 cases. Hum Exp Toxicol 1990; 9:273–279.
  • Sivagnanam S. Potential therapeutic agents in the management of organophosphorus poisoning. Crit Care 2002; 6:260–261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.